Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples